Department of Genetics, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
Medical Clinic III, University Hospital Mainz, Mainz, Germany; and.
Blood Adv. 2018 Nov 27;2(22):3137-3148. doi: 10.1182/bloodadvances.2018025866.
Ectopic expression of the oncogenic transcription factor HoxA9 is a major cause of acute myeloid leukemia (AML). Here, we demonstrate that HoxA9 is a specific substrate of granule proteases. Protease knockout allowed the comprehensive determination of genome-wide HoxA9 binding sites by chromatin immunoprecipitation sequencing in primary murine cells and a human AML cell line. The kinetics of enhancer activity and transcription rates in response to alterations of an inducible HoxA9 were determined. This permitted identification of HoxA9-controlled enhancers and promoters, allocation to their respective transcription units, and discrimination against HoxA9-bound, but unresponsive, elements. HoxA9 triggered an elaborate positive-feedback loop that drove expression of the complete -A locus. In addition, it controlled key oncogenic transcription factors and and directly induced the cell cycle regulators and , as well as telomerase, drawing the essential blueprint for perturbation of proliferation by leukemogenic HoxA9 expression.
致癌转录因子 HoxA9 的异位表达是急性髓细胞白血病 (AML) 的主要原因。在这里,我们证明 HoxA9 是颗粒蛋白酶的特定底物。蛋白酶敲除允许通过染色质免疫沉淀测序在原代鼠细胞和人 AML 细胞系中全面确定全基因组 HoxA9 结合位点。确定了响应诱导的 HoxA9 的变化时增强子活性和转录率的动力学。这允许鉴定 HoxA9 控制的增强子和启动子,将它们分配到各自的转录单元,并区分 HoxA9 结合但无反应的元件。HoxA9 触发了一个复杂的正反馈环,驱动了整个 -A 基因座的表达。此外,它还控制着关键的致癌转录因子和,并直接诱导细胞周期调节剂和 ,以及端粒酶,为白血病致癌 HoxA9 表达对增殖的干扰绘制了基本蓝图。